FUDANZHANGJIANG Calls 28 May 2026 AGM; Seeks RMB300.00 Million A-Share Mandate and Board Re-election

Bulletin Express
04/29

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. has convened its 2026 annual general meeting (AGM) for 1:30 p.m. on 28 May 2026 at No. 308 Cailun Road, Zhangjiang Hi-Tech Park, Shanghai. Key agenda items are as follows:

Special resolution • General mandate: The Board will request authority to issue, allot or deal in additional A-shares up to 20% of the current A-share capital. Aggregate proceeds are capped at RMB300.00 million and may not exceed 20% of net assets. The authorisation will remain valid until the earliest of (i) the 2027 AGM, (ii) 12 months after approval, or (iii) revocation by shareholders.

Ordinary resolutions • FY 2025 reporting: Shareholders will review the Board’s 2025 work report, the A-share annual report and summary, and audited H-share financial statements. • Profit distribution: A 2025 final-dividend proposal will be tabled; details were not disclosed in the notice. • Auditor appointments: Votes will be held to appoint domestic and overseas financial auditors and a domestic internal-control auditor for 2026, with remuneration to be set by the Board. • Compensation: Remuneration for Directors and Supervisors for 2025 and proposals for 2026 will be considered. • Capital-return policy: A three-year (2026-2028) shareholder dividend return plan is up for approval. • Governance matters: Shareholders will vote on a remuneration-management framework for directors and senior executives.

Board composition Re-election/election of the ninth Board session includes: – Executive Directors: Zhao Da Jun and Xue Yan (both standing for re-election) – Non-executive Directors: Zhong Tao (new) and Yu Xiao Yang (re-election) – Independent Non-executive Directors: Wang Hong Guang, Lam Siu Wing and Xu Pei Long (all re-elections)

Shareholder logistics The H-share register will be closed from 21 May to 28 May 2026, inclusive. Holders of H-shares recorded by 4:30 p.m. on 21 May 2026 are entitled to attend and vote. Proxy forms must reach Computershare Hong Kong Investor Services by 1:30 p.m. on 27 May 2026. All resolutions will be decided by poll.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10